Elevation Oncology Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ELEV Nasdaq 8731 https://elevationoncology.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Elevation Oncology Inc

Elevation Oncology Announces Pricing of $50 Million Public Offering - Jun 9th, 2023 2:41 am
Elevation Oncology Announces Launch of Proposed Public Offering - Jun 8th, 2023 8:01 pm
Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 - Jun 3rd, 2023 1:00 pm
Private equity firms among Elevation Oncology, Inc.'s (NASDAQ:ELEV) largest shareholders, saw gain in holdings value after stock jumped 34% last week - May 19th, 2023 10:54 am
Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements - May 15th, 2023 11:30 am
Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 - Apr 26th, 2023 8:05 pm
Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023 - Apr 17th, 2023 2:15 pm
Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year? - Mar 23rd, 2023 1:40 pm
Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023 - Mar 14th, 2023 8:30 pm
Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results - Mar 9th, 2023 12:30 pm
Elevation Oncology to Participate at Upcoming Investor Conferences - Mar 1st, 2023 12:00 pm
Elevation Oncology to Present at the SVB Securities Global Biopharma Conference - Feb 8th, 2023 12:00 pm
Elevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 9th, 2023 12:30 pm
Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition - Jan 6th, 2023 1:15 pm
Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit - Nov 30th, 2022 12:30 pm
Elevation Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress - Nov 3rd, 2022 11:30 am
10 Best One Dollar Stocks To Buy Now - Aug 12th, 2022 1:30 pm
Elevation Oncology Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Aug 4th, 2022 11:30 am
Elevation Oncology to Participate at the Wedbush PacGrow Healthcare Conference - Aug 3rd, 2022 12:00 pm
Elevation Oncology Secures $50 Million Loan Facility with K2 HealthVentures - Jul 28th, 2022 12:50 pm